Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials-Reference-Cited by-同舟云学术

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Published:2013-12 Issue:12 Volume:24 Page:2972-2977
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Templeton A.J.,Vera-Badillo F.E.,Wang L.,Attalla M.,De Gouveia P.,Leibowitz-Amit R.,Knox J.J.,Moore M.,Sridhar S.S.,Joshua A.M.,Pond G.R.,Amir E.,Tannock I.F.

Funder

Canadian Institutes of Health Research

Swiss Cancer Research Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/12/2972/16702195/mdt397.pdf

Reference19 articles.

1. What constitutes reasonable evidence of efficacy and effectiveness to guide oncology treatment decisions?;Sargent;Oncologist,2010

2. Reducing patient eligibility criteria in cancer clinical trials;George;J Clin Oncol,1996

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer;Sridhar;Cancer Chemother Pharmacol,2011

5. A phase III trial of GVAX immunotherapy for prostate cancer in combination with docetaxel versus docetaxel plus prednisone in symptomatic, castration-resistant prostate cancer;Small;Proc ASCO GU Cancer Symp,2009

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial;Cancer Research Communications;2024-08-01

2. Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC;Advances in Therapy;2024-06-25

3. RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain;Seminars in Oncology;2024-06

4. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?;Current Treatment Options in Oncology;2024-02-17

5. Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data;Cancers;2023-12-15